egfr inhibitors

Cetuximab

Products Cetuximab is commercially available as an infusion solution (Erbitux). It has been approved in many countries since 2003. Structure and properties Cetuximab is a recombinant chimeric (human/mouse) IgG1 monoclonal antibody. It is produced by biotechnological methods. Effects Cetuximab (ATC L01XC06) has antitumor and antiangiogenic properties. It is a specific antibody against the epidermal growth … Cetuximab

Panitumumab

Products Panitumumab is commercially available as an infusion solution (Vectibix). It has been approved in many countries since 2008. Structure and properties Panitumumab is a recombinant, fully human IgG2 monoclonal antibody against EGFR. Effects Panitumumab (ATC L01XC08) has antitumor and antiangiogenic properties. The effects are due to binding to the epidermal growth factor receptor (EGFR). … Panitumumab